Unlocking the Power of Systems Thinking in Policymaking: A Path to Stronger Health Systems

By HEOR Staff Writer

July 3, 2023

Discover the untapped potential of systems thinking in shaping effective policies and practices published in a new article. 

Traditionally seen as too conceptual for policy relevance, systems thinking is now gaining traction in high-income countries, with governments embracing adaptive leadership and systemic evaluations. 

But what about low- and middle-income countries? Resource constraints often hinder the institutionalization of systems thinking, making it challenging to replicate successful examples.

To overcome this, the study proposes three key steps:

1️⃣ Theorise and clarify the terminology of applied systems thinking in health policy and systems research (HPSR). By utilising systems modeling and other tools, we can better understand the interactions between interventions and their contexts. 

2️⃣ Encourage greater government investment and institutional incentives to foster long-term collaboration and science-policy partnerships. This will enhance the capacities and practice of systems thinking in policymaking. 

3️⃣ Advocate for funding norms that enable systems thinking in LMICs. Pooling resources and fostering networked institutions can address complexity and adaptive approaches, leading to more impactful outcomes. 

 

To read the full article click on the link below. 

Reference url

Recent Posts

Parkinson's Cognitive Measurement
Parkinson’s Cognitive Measurement and the Impact of Precision on Forecasting

By João L. Carapinha

June 8, 2026

Parkinson's Cognitive Measurement has emerged as the decisive constraint on our ability to forecast cognitive decline in Parkinson disease. A major new analysis shows that even the most advanced machine learning models deliver only chance-level accuracy when predicting individual cognitive trajec...
mifepristone safety study
Mifepristone Safety Study: Ensuring Continued Regulatory Oversight

By João L. Carapinha

June 6, 2026

The mifepristone safety study launched by the FDA in April 2026 is actively collecting high-quality real-world data to determine whether the current Risk Evaluation and Mitigation Strategy (REMS) program still strikes the right balance between clinical benefits and potential harms. S...
cancer productivity Asia-Pacific
Cancer Productivity Disparities in the Asia-Pacific Region

By João L. Carapinha

June 5, 2026

New research exposes a deepening divide in cancer productivity Asia-Pacific, where middle-income countries face rapidly escalating productivity losses from premature cancer deaths and disability, while high-income economies have begun to stabilise their burdens. Between 2010 and 2022, indirect ec...